Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Buprenorphine | 24 | 2023 | 666 | 7.480 |
Why?
|
Opioid-Related Disorders | 33 | 2023 | 2188 | 6.130 |
Why?
|
Opiate Substitution Treatment | 16 | 2023 | 452 | 4.300 |
Why?
|
Substance Withdrawal Syndrome | 7 | 2025 | 628 | 3.080 |
Why?
|
Substance Abuse, Intravenous | 6 | 2020 | 530 | 2.740 |
Why?
|
Hallucinogens | 5 | 2024 | 207 | 2.510 |
Why?
|
Alcoholism | 9 | 2025 | 1981 | 2.380 |
Why?
|
Narcotic Antagonists | 9 | 2023 | 591 | 2.370 |
Why?
|
Endocarditis | 5 | 2024 | 352 | 2.080 |
Why?
|
Substance-Related Disorders | 13 | 2024 | 4429 | 1.980 |
Why?
|
Analgesics, Opioid | 20 | 2023 | 3836 | 1.810 |
Why?
|
Behavior, Addictive | 3 | 2023 | 433 | 1.530 |
Why?
|
Fentanyl | 4 | 2023 | 450 | 1.440 |
Why?
|
Benzodiazepines | 4 | 2025 | 1139 | 1.330 |
Why?
|
Methadone | 7 | 2023 | 317 | 1.330 |
Why?
|
Psychiatry | 5 | 2018 | 1715 | 1.040 |
Why?
|
Substance Abuse Detection | 2 | 2018 | 300 | 0.980 |
Why?
|
Naltrexone | 4 | 2023 | 319 | 0.970 |
Why?
|
Glycerophospholipids | 2 | 2024 | 39 | 0.960 |
Why?
|
Naloxone | 2 | 2020 | 372 | 0.930 |
Why?
|
Amantadine | 1 | 2024 | 59 | 0.930 |
Why?
|
Heroin Dependence | 2 | 2017 | 173 | 0.880 |
Why?
|
Inpatients | 4 | 2021 | 2569 | 0.880 |
Why?
|
Memantine | 1 | 2024 | 111 | 0.870 |
Why?
|
Hospitals, General | 3 | 2025 | 807 | 0.820 |
Why?
|
Peer Group | 2 | 2024 | 698 | 0.770 |
Why?
|
Catatonia | 1 | 2024 | 181 | 0.760 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2023 | 125 | 0.740 |
Why?
|
Cannabinoids | 2 | 2021 | 175 | 0.740 |
Why?
|
Bone Diseases, Infectious | 1 | 2020 | 16 | 0.720 |
Why?
|
Metaphor | 1 | 2020 | 42 | 0.700 |
Why?
|
Endocarditis, Bacterial | 2 | 2024 | 436 | 0.700 |
Why?
|
Primary Dysautonomias | 1 | 2020 | 28 | 0.690 |
Why?
|
Physician Impairment | 1 | 2020 | 71 | 0.670 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2024 | 905 | 0.640 |
Why?
|
Dimethoxyphenylethylamine | 2 | 2014 | 3 | 0.610 |
Why?
|
Cocaine-Related Disorders | 2 | 2024 | 461 | 0.610 |
Why?
|
Ketamine | 1 | 2023 | 524 | 0.570 |
Why?
|
Paranoid Disorders | 1 | 2017 | 61 | 0.560 |
Why?
|
Theophylline | 1 | 2017 | 133 | 0.560 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 181 | 0.550 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 436 | 0.550 |
Why?
|
Crack Cocaine | 1 | 2016 | 33 | 0.550 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2017 | 155 | 0.550 |
Why?
|
Referral and Consultation | 5 | 2020 | 3627 | 0.540 |
Why?
|
Citrus | 1 | 2016 | 50 | 0.540 |
Why?
|
Treatment Refusal | 1 | 2020 | 432 | 0.530 |
Why?
|
Fellowships and Scholarships | 2 | 2018 | 1133 | 0.530 |
Why?
|
Ambulatory Care | 4 | 2023 | 2784 | 0.530 |
Why?
|
Amphetamines | 1 | 2017 | 143 | 0.530 |
Why?
|
Drug Substitution | 1 | 2019 | 291 | 0.530 |
Why?
|
Radial Artery | 1 | 2017 | 188 | 0.490 |
Why?
|
Lysergic Acid Diethylamide | 1 | 2014 | 48 | 0.480 |
Why?
|
Delusions | 1 | 2017 | 301 | 0.470 |
Why?
|
Cannabis | 1 | 2021 | 445 | 0.470 |
Why?
|
Cellulitis | 1 | 2016 | 206 | 0.470 |
Why?
|
Point-of-Care Systems | 1 | 2023 | 1238 | 0.470 |
Why?
|
Hospitalization | 8 | 2024 | 10844 | 0.470 |
Why?
|
Humans | 76 | 2025 | 768298 | 0.460 |
Why?
|
Self-Help Groups | 1 | 2016 | 195 | 0.460 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 4047 | 0.460 |
Why?
|
Bacteremia | 1 | 2020 | 985 | 0.430 |
Why?
|
Leukocytosis | 1 | 2014 | 250 | 0.430 |
Why?
|
Patient Compliance | 3 | 2020 | 2693 | 0.430 |
Why?
|
Perinatal Care | 1 | 2015 | 245 | 0.430 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 746 | 0.410 |
Why?
|
Tachycardia | 1 | 2014 | 598 | 0.400 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.390 |
Why?
|
Patient Acceptance of Health Care | 2 | 2016 | 3230 | 0.390 |
Why?
|
Upper Extremity | 1 | 2016 | 684 | 0.370 |
Why?
|
Patient Care Management | 1 | 2014 | 304 | 0.360 |
Why?
|
Appointments and Schedules | 1 | 2015 | 442 | 0.360 |
Why?
|
Psychosomatic Medicine | 1 | 2011 | 72 | 0.360 |
Why?
|
Cooperative Behavior | 2 | 2015 | 1515 | 0.360 |
Why?
|
Adult | 30 | 2024 | 223622 | 0.350 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1076 | 0.350 |
Why?
|
Gastroplasty | 1 | 2012 | 159 | 0.340 |
Why?
|
Psychotic Disorders | 3 | 2020 | 3279 | 0.340 |
Why?
|
Disclosure | 1 | 2016 | 754 | 0.340 |
Why?
|
Delirium | 1 | 2021 | 1695 | 0.330 |
Why?
|
Program Development | 1 | 2015 | 1298 | 0.330 |
Why?
|
Seizures | 3 | 2019 | 3000 | 0.320 |
Why?
|
Dental Caries | 1 | 2012 | 429 | 0.310 |
Why?
|
Internship and Residency | 3 | 2018 | 5948 | 0.290 |
Why?
|
Adolescent Behavior | 1 | 2016 | 1190 | 0.290 |
Why?
|
Alcohol Drinking | 4 | 2024 | 4049 | 0.280 |
Why?
|
Patient Discharge | 1 | 2020 | 3474 | 0.270 |
Why?
|
Stress Disorders, Post-Traumatic | 2 | 2022 | 4637 | 0.260 |
Why?
|
Hyperglycemia | 1 | 2014 | 1389 | 0.260 |
Why?
|
Female | 33 | 2024 | 397050 | 0.260 |
Why?
|
Suicide, Attempted | 1 | 2014 | 1408 | 0.250 |
Why?
|
Administration, Sublingual | 1 | 2023 | 60 | 0.220 |
Why?
|
Feasibility Studies | 4 | 2020 | 5311 | 0.210 |
Why?
|
Gastric Bypass | 1 | 2012 | 829 | 0.210 |
Why?
|
Education, Medical, Graduate | 2 | 2015 | 2411 | 0.210 |
Why?
|
Pain | 2 | 2023 | 5102 | 0.210 |
Why?
|
Medicine | 1 | 2011 | 948 | 0.210 |
Why?
|
Male | 27 | 2024 | 364870 | 0.210 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 3267 | 0.210 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2023 | 93 | 0.200 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2024 | 452 | 0.200 |
Why?
|
Education, Special | 1 | 2022 | 86 | 0.190 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7458 | 0.190 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2024 | 367 | 0.190 |
Why?
|
Primary Health Care | 2 | 2015 | 4748 | 0.190 |
Why?
|
Curriculum | 1 | 2015 | 3775 | 0.190 |
Why?
|
Middle Aged | 17 | 2024 | 223463 | 0.190 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 162 | 0.190 |
Why?
|
Liver Transplantation | 2 | 2023 | 2399 | 0.190 |
Why?
|
Motivation | 2 | 2022 | 2029 | 0.180 |
Why?
|
Obesity, Morbid | 1 | 2012 | 1306 | 0.180 |
Why?
|
Ethanol | 2 | 2024 | 1333 | 0.180 |
Why?
|
Massachusetts | 2 | 2024 | 8902 | 0.180 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3921 | 0.170 |
Why?
|
Punishment | 1 | 2021 | 95 | 0.170 |
Why?
|
Loperamide | 1 | 2019 | 10 | 0.160 |
Why?
|
Methocarbamol | 1 | 2019 | 8 | 0.160 |
Why?
|
Promethazine | 1 | 2019 | 29 | 0.160 |
Why?
|
Sympatholytics | 1 | 2019 | 82 | 0.160 |
Why?
|
Antipruritics | 1 | 2019 | 31 | 0.160 |
Why?
|
Powders | 1 | 2019 | 79 | 0.160 |
Why?
|
Delayed-Action Preparations | 1 | 2023 | 968 | 0.160 |
Why?
|
Stroke | 1 | 2021 | 9742 | 0.160 |
Why?
|
Antidiarrheals | 1 | 2019 | 46 | 0.160 |
Why?
|
Tobacco Use Disorder | 1 | 2024 | 708 | 0.150 |
Why?
|
Ondansetron | 1 | 2019 | 95 | 0.150 |
Why?
|
Health Services | 1 | 2023 | 756 | 0.150 |
Why?
|
Muscle Relaxants, Central | 1 | 2019 | 93 | 0.150 |
Why?
|
Pregnancy Complications | 1 | 2012 | 2971 | 0.150 |
Why?
|
Clonidine | 1 | 2019 | 170 | 0.150 |
Why?
|
Injections, Subcutaneous | 1 | 2019 | 687 | 0.150 |
Why?
|
Pilot Projects | 3 | 2023 | 8730 | 0.150 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 170 | 0.150 |
Why?
|
Alcohol-Related Disorders | 1 | 2020 | 243 | 0.150 |
Why?
|
Retrospective Studies | 9 | 2024 | 81768 | 0.140 |
Why?
|
Antiemetics | 1 | 2019 | 188 | 0.140 |
Why?
|
Comorbidity | 3 | 2022 | 10588 | 0.140 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5511 | 0.140 |
Why?
|
Injections | 1 | 2020 | 840 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2023 | 1476 | 0.130 |
Why?
|
Somatoform Disorders | 1 | 2019 | 425 | 0.130 |
Why?
|
Medical History Taking | 1 | 2020 | 776 | 0.130 |
Why?
|
Heroin | 1 | 2016 | 120 | 0.130 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4859 | 0.130 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 726 | 0.120 |
Why?
|
Sensation | 1 | 1997 | 337 | 0.120 |
Why?
|
Young Adult | 6 | 2018 | 60048 | 0.120 |
Why?
|
Outpatients | 1 | 2023 | 1603 | 0.120 |
Why?
|
Anisoles | 1 | 2014 | 6 | 0.120 |
Why?
|
Barbiturates | 1 | 2015 | 113 | 0.120 |
Why?
|
Hospital Administration | 1 | 2018 | 353 | 0.120 |
Why?
|
Anticonvulsants | 1 | 2025 | 1923 | 0.120 |
Why?
|
Risperidone | 1 | 2017 | 383 | 0.120 |
Why?
|
Phenethylamines | 1 | 2014 | 95 | 0.120 |
Why?
|
Hypertension | 1 | 2014 | 8615 | 0.120 |
Why?
|
Culture | 1 | 2018 | 623 | 0.110 |
Why?
|
Physicians | 1 | 2012 | 4614 | 0.110 |
Why?
|
Benzylamines | 1 | 2014 | 251 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 997 | 0.110 |
Why?
|
Psychotherapy | 2 | 2019 | 1656 | 0.110 |
Why?
|
Checklist | 1 | 2020 | 843 | 0.110 |
Why?
|
Creatine Kinase | 1 | 2014 | 685 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1191 | 0.100 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1188 | 0.100 |
Why?
|
Data Collection | 2 | 2011 | 3324 | 0.100 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 923 | 0.100 |
Why?
|
Natural Language Processing | 1 | 2021 | 1202 | 0.100 |
Why?
|
Oxycodone | 1 | 2012 | 145 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1197 | 0.090 |
Why?
|
Leukocyte Count | 1 | 2014 | 1605 | 0.090 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1489 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 2661 | 0.080 |
Why?
|
United States | 8 | 2020 | 73144 | 0.080 |
Why?
|
Odds Ratio | 2 | 2020 | 9681 | 0.080 |
Why?
|
Electrocardiography | 1 | 2023 | 6409 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1181 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2348 | 0.080 |
Why?
|
Pregnancy | 3 | 2015 | 30198 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2050 | 0.070 |
Why?
|
Memory | 1 | 1997 | 2210 | 0.070 |
Why?
|
Headache | 1 | 2015 | 1262 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7145 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3312 | 0.070 |
Why?
|
Cognition | 1 | 2023 | 7074 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1990 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3412 | 0.060 |
Why?
|
Mental Disorders | 3 | 2013 | 6876 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3080 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8750 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6319 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15939 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3485 | 0.050 |
Why?
|
Mental Health Services | 1 | 2013 | 1731 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 13019 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2013 | 3736 | 0.040 |
Why?
|
Adjustment Disorders | 1 | 2020 | 68 | 0.040 |
Why?
|
Weight Loss | 1 | 2012 | 2715 | 0.040 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2020 | 300 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65365 | 0.040 |
Why?
|
Hospitals, Psychiatric | 1 | 2020 | 318 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9380 | 0.040 |
Why?
|
Adolescent | 2 | 2016 | 89182 | 0.030 |
Why?
|
Information Systems | 1 | 2018 | 399 | 0.030 |
Why?
|
Risk Factors | 2 | 2015 | 74954 | 0.030 |
Why?
|
Age Factors | 1 | 2013 | 18472 | 0.030 |
Why?
|
Inservice Training | 1 | 2018 | 375 | 0.030 |
Why?
|
Personality Disorders | 1 | 2020 | 729 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 26410 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2019 | 1585 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22292 | 0.030 |
Why?
|
Prevalence | 1 | 2012 | 15868 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1445 | 0.030 |
Why?
|
Advisory Committees | 1 | 2018 | 797 | 0.030 |
Why?
|
Nausea | 1 | 2017 | 682 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2024 | 1447 | 0.030 |
Why?
|
Standard of Care | 1 | 2017 | 570 | 0.030 |
Why?
|
Functional Laterality | 1 | 1997 | 2268 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39405 | 0.020 |
Why?
|
Brain | 1 | 1997 | 27452 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2505 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2020 | 1946 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2754 | 0.020 |
Why?
|
Medicare Part C | 1 | 2013 | 332 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10776 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22389 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8562 | 0.020 |
Why?
|
Aged | 3 | 2020 | 171544 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3960 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21163 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3858 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5126 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8072 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4819 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6881 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7453 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10377 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14154 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26373 | 0.010 |
Why?
|
Logistic Models | 1 | 2013 | 13323 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13499 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2013 | 59683 | 0.000 |
Why?
|